Eurofins Scientific SE Statistics
Share Statistics
Eurofins Scientific SE has 175.96M
shares outstanding. The number of shares has increased by -2.73%
in one year.
| Shares Outstanding | 175.96M |
| Shares Change (YoY) | -2.73% |
| Shares Change (QoQ) | -2.4% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 225.86K, so 0% of the outstanding
shares have been sold short.
| Short Interest | 225.86K |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 158.61 |
Valuation Ratios
The PE ratio is 23.76 and the forward
PE ratio is 14.52.
Eurofins Scientific SE's PEG ratio is
0.24.
| PE Ratio | 23.76 |
| Forward PE | 14.52 |
| PS Ratio | 1.39 |
| Forward PS | 1.1 |
| PB Ratio | 1.81 |
| P/FCF Ratio | 12.21 |
| PEG Ratio | 0.24 |
Financial Ratio HistoryEnterprise Valuation
Eurofins Scientific SE has an Enterprise Value (EV) of 12.65B.
| EV / Sales | 1.82 |
| EV / EBITDA | 9.06 |
| EV / EBIT | 9.59 |
| EV / FCF | 16.01 |
Financial Position
The company has a current ratio of 1.16,
with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.16 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 2.58 |
| Debt / FCF | 4.57 |
| Interest Coverage | 4.82 |
Financial Efficiency
Return on Equity is 7.61% and Return on Invested Capital is 5.74%.
| Return on Equity | 7.61% |
| Return on Assets | 3.73% |
| Return on Invested Capital | 5.74% |
| Revenue Per Employee | $110,868.32 |
| Profits Per Employee | $6,482.07 |
| Employee Count | 62,696 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 15.78 |
Taxes
| Income Tax | 149.1M |
| Effective Tax Rate | 26.88% |
Stock Price Statistics
The stock price has increased by 3.82% in the
last 52 weeks. The beta is 0.81, so Eurofins Scientific SE's
price volatility has been higher than the market average.
| Beta | 0.81 |
| 52-Week Price Change | 3.82% |
| 50-Day Moving Average | 58.77 |
| 200-Day Moving Average | 54.9 |
| Relative Strength Index (RSI) | 56.92 |
| Average Volume (20 Days) | 1,536 |
Income Statement
In the last 12 months, Eurofins Scientific SE had revenue of 6.95B
and earned 406.4M
in profits. Earnings per share was 2.13.
| Revenue | 6.95B |
| Gross Profit | 4.71B |
| Operating Income | 726.2M |
| Net Income | 406.4M |
| EBITDA | 1.4B |
| EBIT | 705.4M |
| Earnings Per Share (EPS) | 2.13 |
Full Income StatementBalance Sheet
The company has 613.9M in cash and 3.61B in
debt, giving a net cash position of -3B.
| Cash & Cash Equivalents | 613.9M |
| Total Debt | 3.61B |
| Net Cash | -3B |
| Retained Earnings | 2.69B |
| Total Assets | 10.89B |
| Working Capital | 342M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 1.32B
and capital expenditures -528.4M, giving a free cash flow of 790.5M.
| Operating Cash Flow | 1.32B |
| Capital Expenditures | -528.4M |
| Free Cash Flow | 790.5M |
| FCF Per Share | 4.15 |
Full Cash Flow StatementMargins
Gross margin is 67.79%, with operating and profit margins of 10.45% and 5.85%.
| Gross Margin | 67.79% |
| Operating Margin | 10.45% |
| Pretax Margin | 7.98% |
| Profit Margin | 5.85% |
| EBITDA Margin | 20.09% |
| EBIT Margin | 10.45% |
| FCF Margin | 11.37% |
